Shots: In the agreement, Aurobindo has obtained the exclusive rights to develop, manufacture & sell COVAXX’s UB-612 vaccine in India & UNICEF & also non-exclusive rights in other selected emerging & developing markets UB-612 is presently being assessed in P-I will be manufactured by Aurobindo in its Hyderabad facility has a manufacturing capacity of 220M […]Read More
Shots: Jenburkt became the second company to launch Favivent (favipiravir) to treat mild to moderate COVID-19 symptoms at a price of Rs. 39/tablet Cipla receives the DCGI approval for Ciplenza (favipiravir, 200mg) targeting the unmet medical needs for COVID-19 treatment options in the country through restricted emergency use. The company will launch Ciplenza in the […]Read More
Shots: Team PharmaShots started their journey on 25 July 2018 and is proudly announcing their completion of one year, with many more to come. PharmaShots has published 1,238 news and articles till date We are grateful to all our subscribers for their affection towards PharmaShots and for subscribing our news alerts. We ensure to put […]Read More
1.Janssen’s Erleada (apalutamide) Receives FDA Approval for Non-Metastatic Castration-Resistant Prostate Cancer (NM-CRPC) Published: 14 Feb,2018 | Tags: Janssen, Erleada, apalutamide, Receives, FDA, Approval, Non-Metastatic Castration-Resistant Prostate Cancer, NM-CRPC 2. Helsinn’s (fosnetupitant + palonosetron) Receives FDA Approval for Managing Chemotherapy-Induced Nausea and Vomiting (CINV) Published: 14 Feb,2018 | Tags: Helsins, fosnetupitant + palonosetron, Receives, FDA, Approval, […]Read More
THE US FDA APPROVALS 1. Pfizer’s Retacrit (epoetin alfa-epbx, biosimilar) Receives FDA Approval for Anemia Published: 15 May, 2018 | Tags: Pfizer, Retacrit, epoetinalfa-epbx, biosimilar, Receives, FDA, Approval, Anemia 2. Pfizer’s Nivestym (filgrastim-aafi, biosmilar) Receives FDA Approval forNeutropenia Published: 20 Jul, 2018 | Tags: (filgrastim-aafi approval biosmilar), Neutropenia, Nivestym, Pfizer, Receives, the […]Read More
PharmaShots Year in Review | Top 10 Pharma News of 2018 1. Celgene to Acquire Juno for its Cellular Immunotherapy & Hematology Portfolio Published: 22 Jan, 2018 | Tags: Celgene, Acquire, Juno, Cellular, Immunotherapy, Hematology Portfolio 2. Sanofi to Acquire Bioverativ for its Hemophilia Products Published: 22 Jan, 2018 | Tags: Sanofi, Acquire, Bioverativ, Treat, […]Read More
Shots: In Oct, 2018 Pfizer appointed Dr. Albert Bourla as its new CEO, successor of Lan C. Read (7 Dec, 2010 – 31 Dec, 2018) In Feb, 2018 Novartis appointed Vasant Narasimhan as its new CEO, successor of Joseph Jimenez (5 Sept, 2017 – 1 Feb, 2018) In March, 2019 Gilead will appoint Daniel O’Day […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
